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In Memoriam
 
“…one should always attempt to
construct an internal image of the
universe of knowledge, and then ask
 
if a given publication can, in any
significant way, modify that image” -
Charles A. Janeway, Jr. (Presidential
Address, AAI, 1998)
I used to comment that it often
seemed as though Charlie already
 
knew the answers to the various
questions being asked in his lab; it
simply was our responsibility to devise
the experiments that would provide
the necessary data - one might say, the
proof of principle. Charlie was a
thinker. He rarely embraced the
 
newest or flashiest technology, perhaps
he did not always devise the most
cutting edge experiments and it could,
possibly, be said that he did not always
provide the definitive answer to a par-
ticular question. But so many times, it
seemed, that when an experimental
approach brought a question to it’s
conclusion, the data ended up simply
proving what Charlie had already
been telling us. In fact in some ways, it
could be argued that Charlie’s greatest
impact on Immunology is the seem-
ingly endless stream of incisive review
and opinion articles, book chapters
and text books that have in some way
influenced or shaped the way nearly
all immunologists think about various
 
aspects of immunology. Indeed,
Charlie’s introductory essay to the
1989 Cold Spring Harbor Symposium
volume “Approaching the asymptote?
Evolution and revolution in immu-
nology” is widely regarded as the sem-
inal contribution that redefined and
focused the field of innate immunity.
 
The Immunologist’s Dirty Little Secret.
 
Charlie attributes his early thoughts on
 
innate immunity to insightful ques-
tions posed by his wife, Dr. Kim
Bottomly, also a world-renowned
immunologist. Kim was puzzled by
data showing that various effector cy-
 
tokines were present before their pro-
duction by effector T cells. Charlie’s
answer to her question asking where
do these cytokines come from was “I
don’t know, but has anyone looked at
the innate immune system”?. To put a
timeframe on this discussion (for us
 
younger immunologists), Pam Bjork-
man had recently astounded the
community with her crystal structure
showing that peptides bound to the
cleft of MHC class I and David Schatz
and Marjorie Oettinger had just re-
ported the cloning of one of the genes
central to adaptive immunity, RAG1.
“(I)n order to obtain readily detect-
able responses to (protein) antigens”
Charlie wrote in this essay, “they must
be incorporated into a remarkable
mixture termed complete Freund’s
adjuvant.” “The most likely possibility
 
(to explain this) is that primitive effec-
tor cells bear receptors that allow rec-
ognition of certain pathogen-associated
molecular patterns that are not found
in the host. I term these receptors
 
pattern recognition receptors
 
.” “I propose
that these pattern recognition systems
activated effector functions of primi-
tive immune systems before the devel-
opment of rearranging gene families
 
and continue to play a role in host
defense today.” Charlie’s prediction
that the immune system is dependent
upon evolutionarily conserved patho-
gen pattern recognition receptors was
dramatically realized when his lab
cloned and characterized the first of
these receptors, human Toll (TLR4)
in 1997. Did Charlie’s words influ-
ence the field? A search of PubMed
reveals that in 2188 papers the authors
refer to “innate immunity” in their
abstracts. 2107 of these papers were
published after 1989.
Charlie’s insights into the field of
innate immunity were, however,
based on his understanding of the
adaptive immune response. His work,
for example, demonstrating that CD4
associates with the TCR helped define
the concept of coreceptors. Charlie’s
work also included critical findings
and conceptual advances that helped
explain superantigens, T cell costimu-
lation and the Th1/Th2 paradigm, as
well as work that characterized the
peptide cargo presented by mouse
MHC class II molecules. Charlie’s
work on adaptive immunity was
largely based upon his interest in un-
derstanding how the TCR interacts
with MHC. Charlie was fascinated by
how TCR interactions with self-pep-
tide:self-MHC during thymic devel-
opment led to a TCR repertoire that
was “self-referential.” In recent work,
he also proposed that the B cell reper-
toire was also self-referential as a result
of BCR interactions with self anti-
gens. Understanding the self-referen-
tial nature of lymphocytes, Charlie
proposed, was critical for understand-
ing autoimmunity and the functions of
T suppressor cells.
While Charlie was renowned for
speculation, personally he enjoyed the
hard facts. I remember explaining to
Charlie during our first meeting that I
wanted to be a postdoc in his lab be-
cause he always seemed to be working
on “the big picture.” Charlie replied
something along the lines of “seeing
 
the big picture depends upon generat-
ing lots of data!”. Indeed, he frequently
reminded us that the discussion of a
paper might be interesting, but “it’s
the results section that will be impor-
tant over time.” Lab members always
looked forward to phone calls from
Charlie in which he would enthusias-
tically report the latest findings from
whatever meeting he was attending.
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In Memoriam
 
There is little doubt, however, that
Charlie’s favorite data was the identifi-
cation of human Toll (now called
TLR4) and the demonstration that it
could induce B7.1 and B7.2 on APCs.
So perhaps as you contemplate your
data in an effort to construct your in-
ternal image of the universe of knowl-
edge, you will pause and remember
“the man in the floppy red hat,” Dr.
Charles Alderson Janeway, Jr.
Charlie will be deeply missed by his
three daughters, Katie, Hannah and
Megan, his wife, Dr. Kim Bottomly,
 
his friends, former trainees, scientists
around the world and, unknowingly,
by the people he sought to help by
understanding the immune system in
health and disease.
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